Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,662 | 80,630 | 111,471 | 141,282 | 168,693 |
| TOTAL | $66,493 | $86,425 | $116,406 | $147,511 | $175,307 |
| Non-Current Assets | |||||
| PPE Net | 1,134 | 1,363 | 1,603 | 1,965 | 2,210 |
| Other Non-Current Assets | 1,011 | 1,409 | 1,649 | 1,886 | 2,120 |
| TOTAL | $2,145 | $2,772 | $3,252 | $3,851 | $4,330 |
| Total Assets | $68,638 | $89,197 | $119,658 | $151,362 | $179,637 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,800 | 17,751 | 26,720 | 34,006 | 32,084 |
| TOTAL | $17,462 | $19,260 | $28,344 | $35,602 | $33,653 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 19,806 | 20,221 | 20,642 | 21,057 | 21,468 |
| TOTAL | $19,806 | $20,221 | $20,642 | $21,057 | $21,468 |
| Total Liabilities | $37,268 | $39,481 | $48,986 | $56,659 | $55,121 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,336 | 48,116 | 48,097 | 47,936 | 47,803 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -460,569 | -439,497 | -416,263 | -389,338 | -356,013 |
| TOTAL | $31,370 | $49,716 | $70,672 | $94,703 | $124,516 |
| Total Liabilities And Equity | $68,638 | $89,197 | $119,658 | $151,362 | $179,637 |